Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bikker

Showing results (391-400 of 402) with videos related to

Pageof 41
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Selective tumor antigen vaccine delivery to human CD169<sup>+</sup> antigen-presenting cells using ganglioside-liposomesAlsya J Affandi, Joanna Grabowska, Katarzyna Olesek, et al.
Human Molecular Genetics|October 21, 2022
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetranceJaël S Copier, Marianne Bootsma, Chai A Ng, et al.
Gastroenterology|November 7, 2007
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's diseaseMarcus Renner, Gaby Bergmann, Inge Krebs, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugarsAmar Ghisaidoobe, Pieter Bikker, Arjan C J de Bruijn, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter studyZahurul A Bhuiyan, Jan D H Jongbloed, Jasper van der Smagt, et al.
Environmental Toxicology and Chemistry|March 26, 2019
Rethinking microplastics as a diverse contaminant suiteChelsea M Rochman, Cole Brookson, Jacqueline Bikker, et al.
The American Journal of Cardiology|July 23, 2013
Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriersJudith A Groeneweg, Paul A van der Zwaag, Louise R A Olde Nordkamp, et al.
European Heart Journal|January 25, 2015
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriersAditya Bhonsale, Judith A Groeneweg, Cynthia A James, et al.
European Journal of Medical Genetics|March 21, 2015
Phenotype and genotype in 103 patients with tricho-rhino-phalangeal syndromeSaskia M Maas, Adam C Shaw, Hennie Bikker, et al.
Pageof 41

Showing results (391-400 of 402) with videos related to

Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Selective tumor antigen vaccine delivery to human CD169<sup>+</sup> antigen-presenting cells using ganglioside-liposomesAlsya J Affandi, Joanna Grabowska, Katarzyna Olesek, et al.
Human Molecular Genetics|October 21, 2022
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetranceJaël S Copier, Marianne Bootsma, Chai A Ng, et al.
Gastroenterology|November 7, 2007
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's diseaseMarcus Renner, Gaby Bergmann, Inge Krebs, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugarsAmar Ghisaidoobe, Pieter Bikker, Arjan C J de Bruijn, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter studyZahurul A Bhuiyan, Jan D H Jongbloed, Jasper van der Smagt, et al.
Environmental Toxicology and Chemistry|March 26, 2019
Rethinking microplastics as a diverse contaminant suiteChelsea M Rochman, Cole Brookson, Jacqueline Bikker, et al.
The American Journal of Cardiology|July 23, 2013
Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriersJudith A Groeneweg, Paul A van der Zwaag, Louise R A Olde Nordkamp, et al.
European Heart Journal|January 25, 2015
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriersAditya Bhonsale, Judith A Groeneweg, Cynthia A James, et al.
European Journal of Medical Genetics|March 21, 2015
Phenotype and genotype in 103 patients with tricho-rhino-phalangeal syndromeSaskia M Maas, Adam C Shaw, Hennie Bikker, et al.
Pageof 41